These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17200222)
1. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval. Bibbins-Domingo K; Fernandez A Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222 [TBL] [Abstract][Full Text] [Related]
2. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective. Temple R; Stockbridge NL Ann Intern Med; 2007 Jan; 146(1):57-62. PubMed ID: 17200223 [TBL] [Abstract][Full Text] [Related]
3. BiDil for heart failure in black patients. Kahn JD Ann Intern Med; 2007 Aug; 147(3):215; author reply 215-6. PubMed ID: 17679713 [No Abstract] [Full Text] [Related]
4. BiDil for heart failure in black patients. Bibbins-Domingo K; Fernandez A Ann Intern Med; 2007 Aug; 147(3):214-5; author reply 215-6. PubMed ID: 17679712 [No Abstract] [Full Text] [Related]
5. Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients. Ellison GT; Kaufman JS; Head RF; Martin PA; Kahn JD J Law Med Ethics; 2008; 36(3):449-57. PubMed ID: 18840235 [TBL] [Abstract][Full Text] [Related]
6. U.S. to review drug intended for one race. Saul S N Y Times Web; 2005 Jun; ():A1, A15. PubMed ID: 15966118 [No Abstract] [Full Text] [Related]
14. Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone. Harv Heart Lett; 2005 Nov; 16(3):1-2. PubMed ID: 16363036 [No Abstract] [Full Text] [Related]
15. How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine. Kahn J Yale J Health Policy Law Ethics; 2004; 4(1):1-46. PubMed ID: 15052858 [No Abstract] [Full Text] [Related]
16. F.D.A. approves a heart drug for African-Americans. Saul S N Y Times Web; 2005 Jun; ():C2. PubMed ID: 15981400 [No Abstract] [Full Text] [Related]
17. "Special treatment": BiDil, Tuskegee, and the logic of race. Reverby SM J Law Med Ethics; 2008; 36(3):478-84. PubMed ID: 18840239 [TBL] [Abstract][Full Text] [Related]
18. Prescribing BiDil: is it black and white? Haga SB; Ginsburg GS J Am Coll Cardiol; 2006 Jul; 48(1):12-4. PubMed ID: 16814642 [TBL] [Abstract][Full Text] [Related]